arrow
Back
K

Kentaro Yamazaki

Shizuoka Cancer Center

5H-index
17Paper Count
85Citation Count
Published Papers 4
Publication Date
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study
err2025-10-02
err0
errOAAI
errKazumasa Yamamoto; Hideaki Bando; Toshihiro Misumi; Tomomi Nishikawa; Masashi Wakabayashi; Kentaro Yamazaki; Yoshihiko Maehara; Eiji Oki; Leonard B Saltz; Jean-Yves Douillard; Cornelis JA Punt; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Volker Heinemann; Chiara Cremolini; J. Randolph Hecht; Hans-Joachim Schmoll; Goro Nakayama; Heinz-Josef Lenz; Thierry Andre; Qian Shi; Aimery de Gramont; Kohei Shitara; Takayuki Yoshino
errShare
errSave
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study
err2025-09-26
err0
errOAAI
errAndo, Koji MD, PhD; Hamabe, Atsushi MD, PhD; Nakamura, Yoshiaki MD, PhD; Watanabe, Jun MD, PhD; Hirata, Keiji MD, PhD; Kataoka, Kozo MD, PhD; Miyo, Masaaki MD, PhD; Kato, Kentaro MD; Akazawa, Naoya MD; Kagawa, Yoshinori MD, PhD; Yokota, Mitsuru MD, PhD; Yamazaki, Kentaro MD, PhD; Mishima, Saori MD, PhD; Yukami, Hiroki MD; Kotani, Daisuke MD, PhD; Bando, Hideaki MD, PhD; Laliotis, George MD, MHA, MPH, MBA; Sharma, Shruti PhD; Palsuledesai, Charuta C. PhD; Rabinowitz, Matthew PhD; Jurdi, Adham MD; Liu, Minetta C. MD; Aleshin, Alexey MD; Taniguchi, Hiroya MD, PhD; Takemasa, Ichiro MD, PhD; Kato, Takeshi MD, PhD; Yoshino, Takayuki MD, PhD; Oki, Eiji MD, PhD
errShare
errSave
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan
err2025-09-01
err0
errOAAI
errDaisuke Kotani; Takayuki Yoshino; Toshiki Masuishi; Yu Sunakawa; Atsuo Takashima; Kentaro Yamazaki; Hisato Kawakami; Tomohiro Nishina; Yoshito Komatsu; Taito Esaki; Cathy Eng; Stacey Ukrainskyj; Rajash Pallai; Shivani Nanda; Zhao Yang; William Schelman; Marek Kania; Taroh Satoh
errShare
errSave
First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results
err2022-06-01
err3
errOAAI
errMuro, K.; Watanabe, J.; Shitara, K.; Yamazaki, K.; Ohori, H.; Shiozawa, M.; Yasui, H.; Oki, E.; Sato, T.; Naitoh, T.; Komatsu, Y.; Kato, T.; Hihara, M.; Soeda, J.; Yamamoto, K.; Akagi, K.; Ochiai, A.; Uetake, H.; Yoshino, T.
errShare
errSave